Haleon, the former consumer healthcare business of GSK, has raised its full-year revenue forecasts after sales were boosted by price rises.
The FTSE 100 company said revenue had risen 10.4 per cent to £5.7 billion in the six months to the end of June, with a mix of prices up 7.5 per cent and volumes rising 2.9 per cent.
Adjusted operating profit rose 8.9 per cent to £1.2 billion.
So, adjust this for inflation then. If volume’s up 3%, profits from price adjustments are up 6% (ignoring that marginal sales are likely most profitable etc) and then, well, are profits actually up in real terms or not? Depends upon hte inflation rate, right? Which is?
